# Spironolactone Versus Prednisolone in DMD

> **NCT03777319** · PHASE1 · TERMINATED · sponsor: **Kevin Flanigan** · enrollment: 2 (actual)

## Conditions studied

- Muscular Dystrophy, Duchenne

## Interventions

- **DRUG:** Spironolactone
- **DRUG:** Prednisolone

## Key facts

- **NCT ID:** NCT03777319
- **Lead sponsor:** Kevin Flanigan
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-12-05
- **Primary completion:** 2021-09-27
- **Final completion:** 2021-11-30
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Inability to recruit participants.
- **Last updated:** 2023-10-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03777319

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03777319, "Spironolactone Versus Prednisolone in DMD". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03777319. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*